Seer, Inc. reported a 22% increase in revenue for the first quarter of 2023, reaching $4.1 million. This growth was primarily driven by increased sales of consumable kits related to the Proteograph Product Suite. The company's net loss was $24.0 million, slightly higher than the previous year. Seer reaffirms its full-year 2023 revenue guidance of $23 million to $25 million.
Revenue for Q1 2023 reached $4.1 million, a 22% increase year-over-year.
Product-related revenue was $3.6 million, including $1.3 million from related parties.
Gross profit for Q1 2023 was $2.1 million, with a gross margin of 51%.
Net loss for Q1 2023 was $24.0 million, compared to $23.6 million in the prior year period.
Seer anticipates full year 2023 revenue to be in the range of $23 million to $25 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance